Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$343.0 - $410.68 $667,821 - $799,593
1,947 New
1,947 $792,000
Q4 2022

Jan 27, 2023

BUY
$285.76 - $321.48 $1.32 Million - $1.48 Million
4,615 New
4,615 $0
Q2 2021

Aug 10, 2021

SELL
$187.49 - $221.1 $47,247 - $55,717
-252 Closed
0 $0
Q1 2021

May 12, 2021

SELL
$207.02 - $241.31 $3,933 - $4,584
-19 Reduced 7.01%
252 $54,000
Q4 2020

Mar 24, 2021

BUY
$207.01 - $276.09 $4,554 - $6,073
22 Added 8.84%
271 $64,000
Q4 2020

Feb 16, 2021

BUY
$207.01 - $276.09 $51,545 - $68,746
249 New
249 $58,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Alpha Dna Investment Management LLC Portfolio

Follow Alpha Dna Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Dna Investment Management LLC with notifications on news.